Risk of Share-Value Dilution Through the Exercise of Stock Acquisition Rights
First written in FY2018. 18 of 26 entries say "Materialised", first in FY2019-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「As of 31 March 2026, potential shares equivalent to 0.1% of the total number of shares issued after deducting treasury shares, or 55,300 shares, existed.」
Potential shares declined from 0.2%, or 156,700 shares, in the previous fiscal year to 0.1%, or 55,300 shares. The possibility of dilution from the exercise of share acquisition rights remains. - FY2026-H1MaterialisedAnnual report
「Change in total shares issued (shares) 30,600 Note 1. This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 30,600 shares, with dilution from potential shares continuing as actual share issuance. - FY2025MitigatedAnnual report
「As of 31 March 2025, potential shares equivalent to 0.1% of the total number of shares issued after deducting treasury shares, or 97,600 shares, existed.」
Potential shares declined from 0.2%, or 156,700 shares, in the previous fiscal year to 0.1%, or 97,600 shares. - FY2024MitigatedAnnual report
「As of 31 March 2024, potential shares equivalent to 0.2% of the total number of shares issued after deducting treasury shares, or 156,700 shares, existed.」
Potential shares declined from 0.5%, or 369,500 shares, in the previous fiscal year to 0.2%, or 156,700 shares. - FY2024-Q3MaterialisedAnnual report
「1 October 2023–31 December 2023 31,500 79,215,500 (Note) 1. These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 31,500 shares, with dilution from potential shares continuing to materialise as actual share issuance. The issuance of a further 51,900 shares in January 2024 was also reported. - FY2024-Q2MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 12,800 79,184,000 1 2,376 1 2,355 (Note) These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 12,800 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 59,700 79,171,200 19 2,375 19 2,354 (Note) These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 59,700 shares, with dilution from potential shares continuing as actual share issuance. - FY2023MitigatedAnnual report
「As of 31 March 2023, potential shares equivalent to 0.5% of the total number of shares issued after deducting treasury shares, or 369,500 shares, existed.」
Potential shares declined from 0.9%, or 696,600 shares, in the previous fiscal year to 0.5%, or 369,500 shares. However, the possibility of dilution from the exercise of share acquisition rights remains. - FY2023-Q3MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 1 78,400 79,074,100 6 2,351 6 2,329 (Note) 1. These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 78,400 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2023-Q2MaterialisedAnnual report
「1 July 2022–30 September 2022 (Note) 27,600 78,995,700 (Note) These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 27,600 shares from July to September 2022, with dilution from potential shares continuing to materialise as actual share issuance. - FY2023-Q1MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 1 28,800 78,968,100 3 2,342 3 2,321 (Note) 1. These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 28,800 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2022MitigatedAnnual report
「As of 31 March 2022, potential shares equivalent to 0.9% of the total number of shares issued after deducting treasury shares, or 696,600 shares, existed.」
Potential shares declined from 2.0%, or 1,548,700 shares, in the previous fiscal year to 0.9%, or 696,600 shares. - FY2022-Q3MaterialisedAnnual report
「1 October 2021–31 December 2021 Note 92,100 78,641,300 13 2,314 13 2,293 Note 1. This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 92,100 shares, with the dilution risk continuing to materialise as actual share issuance. - FY2022-Q2MaterialisedAnnual report
「1 July 2021–30 September 2021 (Note) 1 348,800 78,549,200 23 2,301 23 2,280 (Note) 1. These were issued through the exercise of stock acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 348,800 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2022-Q1MaterialisedAnnual report
「1 April 2021–30 June 2021 Note 1 110,000 Note 1. This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 110,000 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2021MitigatedAnnual report
「As of 31 March 2021, potential shares equivalent to 2.0% of the total number of shares issued after deducting treasury shares, or 1,548,700 shares, existed.」
Although the potential-share ratio declined from 6.0% previously to 2.0%, the possibility of dilution from the exercise of share acquisition rights remains. - FY2021-Q3MaterialisedAnnual report
「1 October 2020–31 December 2020 Note 1 336,400 77,464,000 25 2,223 25 2,202 Note 1. This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 336,400 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2021-Q2MaterialisedAnnual report
「1 July 2020–30 September 2020 Note 1 281,600 77,127,600 12 2,092 12 2,071 This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 281,600 shares from July to September 2020, with dilution from potential shares continuing to materialise as actual share issuance. - FY2021-Q1MaterialisedAnnual report
「1 April 2020–30 June 2020 Note 38,400 76,846,000 12 2,092 12 2,071 This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 38,400 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2020-Q3MaterialisedAnnual report
「1 October 2019–31 December 2019 Note 1 384,000 This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 384,000 shares, with dilution from potential shares continuing to materialise as actual share issuance. - FY2020-Q2MaterialisedAnnual report
「1 July 2019–30 September 2019 179,200 75,852,400 12 2,105 12 2,084」
The exercise of share acquisition rights resulted in the issuance of 179,200 shares from July to September 2019, with dilution from potential shares continuing to materialise as actual share issuance. - FY2020-Q1MaterialisedAnnual report
「1 April 2019–30 June 2019 Note 1 203,200 75,673,200 12 2,092 12 2,071 This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 203,200 shares during the quarter, with dilution from potential shares continuing to materialise as actual share issuance. - FY2019MitigatedAnnual report
「As of 31 March 2019, potential shares equivalent to 6.0% of the total number of shares issued after deducting treasury shares, or 4,534,100 shares, existed.」
Potential shares were updated from the previously reported 7.31%, or 2,714,600 shares, to 6.0% of shares issued after deducting treasury shares, or 4,534,100 shares. Dilution from the exercise of share acquisition rights continues to occur. - FY2019-Q4MaterialisedAnnual report
「1 December 2018–28 February 2019 Note 1 604,800 This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 604,800 shares, indicating further share issuance through exercise from the previously reported 552,000 shares. - FY2019-Q3MaterialisedAnnual report
「This resulted from the exercise of share acquisition rights.」
The exercise of share acquisition rights resulted in the issuance of 552,000 shares, with part of the dilution risk from potential shares materialising as an actual share issuance. - FY2018First statedAnnual report
「As of 31 May 2018, potential shares equivalent to 7.31% of the total number of shares issued, or 2,714,600 shares, existed. If these stock options are exercised, the value per share may be diluted.」
The dilution risk was newly quantified, with potential shares underlying stock options equivalent to 7.31% of total shares issued, or 2,714,600 shares.